Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kauder, Steven E ^a   Santell, Lydia ^a   Mai, Elaine ^a   Wright, Lilyan Y ^a   Luis, Elizabeth ^a   N'Diaye, Elsa N ^a   Lutman, Jeff ^a   Ratti, Navneet ^a   Sa, Susan M ^a   Maun, Henry R ^a   Stefanich, Eric ^a   Gonzalez, Lino C ^a   Graham, Robert R ^a   Diehl, Lauri ^a   Faubion Jr , William A ^b   Keir, Mary E ^a   Young, Judy ^a   Chaudhuri, Amitabha ^a,c   Lazarus, Robert A ^a   Egen, Jackson G ^a  

^a GENENTECH INC   (United States)

^b MAYO CLINIC   (United States)

^c SCIGENOM LABS PVT LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3T3 CELLS; ALLELES; ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICE; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84893503432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083958     Document Type: Article

References (56)

1. Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
2. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.
3. Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, et al. (2009) Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136: 523-529 e523.
4. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
5. Consortium WTCC (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
6. Franke A, Balschun T, Sina C, Ellinghaus D, Hasler R, et al. (2010) Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet 42: 292-294.
7. Goyette P, Lefebvre C, Ng A, Brant SR, Cho JH, et al. (2008) Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 1: 131-138.
8. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
9. Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, et al. (1994) RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 13: 3524-3532. (Pubitemid 24246189)
10. Wang MH, Ronsin C, Gesnel MC, Coupey L, Skeel A, et al. (1994) Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266: 117-119. (Pubitemid 24345331)
11. Donate LE, Gherardi E, Srinivasan N, Sowdhamini R, Aparicio S, et al. (1994) Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci 3: 2378-2394.
12. Wang MH, Yoshimura T, Skeel A, Leonard EJ (1994) Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem 269: 3436-3440. (Pubitemid 24237662)
13. Wang MH, Skeel A, Leonard EJ (1996) Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 97: 720-727. (Pubitemid 26057091)
14. Nanney LB, Skeel A, Luan J, Polis S, Richmond A, et al. (1998) Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. J Invest Dermatol 111: 573-581. (Pubitemid 28452315)
15. Ganesan R, Kolumam GA, Lin SJ, Xie MH, Santell L, et al. (2011) Proteolytic activation of pro-macrophage-stimulating protein by hepsin. Mol Cancer Res 9: 1175-1186.
16. Iwama A, Wang MH, Yamaguchi N, Ohno N, Okano K, et al. (1995) Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86: 3394-3403.
17. Okino T, Egami H, Ohmachi H, Takai E, Tamori Y, et al. (2001) Immunohistochemical analysis of distribution of RON receptor tyrosine kinase in human digestive organs. Dig Dis Sci 46: 424-429. (Pubitemid 32242694)
18. Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, et al. (1995) The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11: 2627-2637. (Pubitemid 26023831)
19. Medico E, Mongiovi AM, Huff J, Jelinek MA, Follenzi A, et al. (1996) The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7: 495-504.
20. Danilkovitch A, Skeel A, Leonard EJ (1999) Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanism. Exp Cell Res 248: 575-582. (Pubitemid 29394817)
21. Danilkovitch A, Donley S, Skeel A, Leonard EJ (2000) Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol 20: 2218-2227. (Pubitemid 30123837)
22. Santoro MM, Gaudino G, Marchisio PC (2003) The MSP receptor regulates α6β4 and α3β1 integrins via 14-3-3 proteins in keratinocyte migration. Dev Cell 5: 257-271. (Pubitemid 37006470)
23. Yao HP, Zhou YQ, Zhang R, Wang MH (2013) MSP-RON signalling in cancer: pathogenesis and therapeutic potential. Nat Rev Cancer 13: 466-481.
24. Chen YQ, Fisher JH,Wang MH (1998) Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J Immunol 161: 4950-4959. (Pubitemid 28492076)
25. Morrison AC, Correll PH (2002) Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J Immunol 168: 853-860. (Pubitemid 34049588)
26. Morrison AC, Wilson CB, Ray M, Correll PH (2004) Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 172: 1825-1832. (Pubitemid 38116831)
27. Wilson CB, Ray M, Lutz M, Sharda D, Xu J, et al. (2008) The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J Immunol 181: 2303-2310.
28. Sharda DR, Yu S, Ray M, Squadrito ML, De Palma M, et al. (2011) Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J Immunol 187: 2181-2192.
29. Waltz SE, Eaton L, Toney-Earley K, Hess KA, Peace BE, et al. (2001) Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J Clin Invest 108: 567-576. (Pubitemid 32777736)
30. Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T, et al. (1997) Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct 1: 69-83.
31. Benight NM, Waltz SE (2012) Ron receptor tyrosine kinase signaling as a therapeutic target. Expert Opin Ther Targets 16: 921-931.
32. Chaudhuri A, Wilson NS, Yang B, Paler Martinez A, Liu J, et al. (2013) Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages. Immunol Cell Biol 91: 451-460.
33. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317.
34. Gorlatova N, Chao K, Pal LR, Araj RH, Galkin A, et al. (2011) Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution. PLoS One 6: e27269.
35. Hauser F, Deyle C, Berard D, Neukirch C, Glowacki C, et al. (2012) Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease. Genes Immun 13: 321-327.
36. Faubion WA, Jr., Fletcher JG, O'Byrne S, Feagan BG, de Villiers WJ, et al. (2013) EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging. Am J Gastroenterol.
37. Ganesan R, Zhang Y, Landgraf KE, Lin SJ, Moran P, et al. (2012) An allosteric anti-hepsin antibody derived from a constrained phage display library. Protein Eng Des Sel 25: 127-133.
38. Chaudhuri A, Xie MH, Yang B, Mahapatra K, Liu J, et al. (2011) Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET. J Biol Chem 286: 32762-32774.
39. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, et al. (2008) Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28: 271-284.
40. Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239.
41. Jubb AM, Pham TQ, Frantz GD, Peale FV Jr., Hillan KJ (2006) Quantitative in situ hybridization of tissue microarrays. Methods Mol Biol 326: 255-264.
42. Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11: 36-42.
43. Carafoli F, Chirgadze DY, Blundell TL, Gherardi E (2005) Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein. FEBS J 272: 5799-5807. (Pubitemid 41689352)
44. Chao KL, Tsai IW, Chen C, Herzberg O (2012) Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase. PLoS One 7: e41912.
45. Stamos J, Lazarus RA, Yao X, Kirchhofer D, Wiesmann C (2004) Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J 23: 2325-2335. (Pubitemid 38954840)
46. The PyMOL Molecular Graphics System, Version 1.4.1 Schrodinger, LLC.
47. Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA, et al. (2011) Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology 53: 1618-1628.
48. Montero-Julian FA, Dauny I, Flavetta S, Ronsin C, Andre F, et al. (1998) Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor. Hybridoma 17: 541-551. (Pubitemid 29024640)
49. Wahl RC, Costigan VJ, Batac JP, Chen K, Cam L, et al. (1997) Mutation of Cys672 allows recombinant expression of activatible macrophage-stimulating protein. J Biol Chem 272: 15053-15056. (Pubitemid 27255515)
50. Danilkovitch A, Miller M, Leonard EJ (1999) Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain binding. J Biol Chem 274: 29937-29943.
51. Wang MH, Julian FM, Breathnach R, Godowski PJ, Takehara T, et al. (1997) Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain. J Biol Chem 272: 16999-17004. (Pubitemid 27289804)
52. Yoshimura T, Yuhki N, Wang MH, Skeel A, Leonard EJ (1993) Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 268: 15461-15468. (Pubitemid 23222036)
53. Brunelleschi S, Penengo L, Lavagno L, Santoro C, Colangelo D, et al. (2001) Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br J Pharmacol 134: 1285-1295. (Pubitemid 33097259)
54. Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, et al. (2011) Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 43: 17-19.
55. Srivastava B, Mells GF, Cordell HJ, Muriithi A, Brown M, et al. (2012) Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scand J Gastroenterol 47: 820-826.
56. Leonard EJ, Skeel A (1996) Hepatic catabolism of intravenously administered pro-macrophage-stimulating protein in mice. J Leukoc Biol 60: 453-458. (Pubitemid 26356769)